Laparoscopic Devices Market

The market for Laparoscopic Devices was estimated at $11.2 billion in 2025; it is anticipated to increase to $17.0 billion by 2030, with projections indicating growth to around $25.9 billion by 2035.

Report ID:DS1801095

Author:Debadatta Patel - Senior Consultant

Published Date:January 2025

Datatree

Life Science

Medical Device

Laparoscopic Devices

Customization Available

Laparoscopic Devices - 2025-2035

Market Outlook
Market Key Insights
Growth Opportunity
Market Dynamics
Application
Recent Development
Impact Analysis

Report Summary

Market Data

Methodology

Table of Contents

Report Summary

Market Data

Methodology

Table of Contents

Global Laparoscopic Devices Market Outlook

Revenue, 2025

$11.2B

Forecast, 2035

$25.9B

CAGR, 2026 - 2035

8.8%

The Laparoscopic Devices industry revenue is expected to be around $11.2 billion in 2026 and expected to showcase growth with 8.8% CAGR between 2026 and 2035. The market for laparoscopic devices is being driven by increasing surgical procedures, rising rates of obesity and gastrointestinal disorders, and also the emphasis on reduced hospital stays and quicker recovery for patients, which is encouraging the use of minimally invasive surgery. Growing availability of advanced laparoscopic technology, alongside better trained surgeons and the increased presence of modern operating theatre facilities, is driving the laparoscopic market. Laparoscopic devices are now having their impact felt in long term surgical planning, due in part to a decrease in complications associated with their use compared with open surgery and to their greater adoption by surgeons in the developing world.

The equipment used in laparoscopic surgery includes instruments such as hand instruments, trocar systems, visualisation systems and insufflators. These devices allow surgeons to dissect and manage tissue in a precise manner through incisions which are small. The majority of the demand for this technology is found in bariatric surgery and general and colorectal surgical procedures. It is also utilised in gynaecological and urological procedures. In total, bariatric and other procedures make up nearly 50% of demand. In 2025, reusable products were the leading of product used in laparoscopic devices, accounting for sales of $6.87 billion. This highlights the significance of factors including sustainability, durability and cost effectiveness to the medical sector. The trend towards better 3D visuals, ergonomic tools and the increasing use of robots in laparoscopic surgery is pushing up the effectiveness of medical equipment, improving working conditions for surgeons and causing more frequent replacements and upgrades in both old and expanding healthcare markets.

Laparoscopic Devices market outlook with forecast trends, drivers, opportunities, supply chain, and competition 2025-2035 — Laparoscopic Devices Market Outlook

Market Key Insights

The Laparoscopic Devices market is projected to grow from $11.2 billion in 2025 to $25.9 billion in 2035. This represents a CAGR of 8.8%, reflecting rising demand across Bariatric, Urological, and Gynecological.
Major contributors to this market are B. Braun Melsungen AG, Johnson & Johnson and Medtronic plc. They are the companies that influence the competitive market landscape.
The major markets for laparoscopic equipment are the United States and Germany. These two countries will also have the highest growth rates in the industry, with 6.4 to 9.2% annual growth from 2025 to 2030.
The highest growth rates are anticipated in emerging markets such as India, Brazil and South Africa, with growth rates ranging from 8.4% to 11%.
Adoption of robotic assistance is forecast to increase the laparoscopic surgical market by $2 billion by 2030.
Over the coming decade the global laparoscopic instruments industry is expected to grow by $14.8 billion. Growth is expected to be particularly strong for manufacturers who specialise in urological and gynecological devices.
The market for laparoscopic equipment is anticipated to experience an increase of 132% by 2035. This rise is directly related to the development and employment of minimal invasive surgery techniques. Furthermore, a significant boost to the market is expected due to recent improvements in laparoscopic technology.

Laparoscopic Devices - Country Share Analysis

Opportunities in the Laparoscopic Devices

Demand in gynecologic oncology for laparoscopic equipment is escalating thanks to increasing cancer in India and also increased government spending on hospitals. The trend among surgeons is to utilise gynecologic laparoscopy to minimize blood loss and the associated risk of infection, without reducing the safety aspect of cancer treatment. Lack of access to high definition laparoscopes, standardized trocar sets and advanced closure tools continues to be a problem for many second and third level hospitals. The gap in the market could be exploited by companies offering gynaecological training, financial services and procedure specific instruments. Laparoscopes and closure instruments will be the fastest growing gynaecological products in India.

Growth Opportunities in North America and Asia Pacific

The market for laparoscopic devices in North America is driven by a strong demand for minimally invasive surgical procedures in the fields of bariatric and colorectal surgery. This is particularly evident in bariatric surgery where the obesity rate is high and where there are a variety of reimbursement options available. Among the companys principal opportunities are laparoscopic instruments and energy based equipment for laparoscopic procedures. Also of interest are systems which allow for three dimensional imaging. Though intense competition is witnessed in the medical equipment industry, where top multi national brands have a strong hold on high end devices and capital equipment, there are still opportunities for brands catering to the budget conscious sector. Such sectors include clinics. The regions key drivers are the mature surgical training sector, the current shift to outpatient laparoscopic surgery, stringent infection control measures that require the use of disposable equipment, and the consolidation of hospitals which benefits suppliers who offer bundles of laparoscopic equipment and data enabled servicing.

The market for laparoscopic surgical equipment in the Asia Pacific region is a rapidly growing one. Gynaecological and colorectal surgical procedures are currently the most prominent applications. This growth is driven by a number of factors including rising awareness of womens health issues and an increasing number of people undergoing screening for colorectal cancer. In the urban region's of the region there is an increasing adoption of laparoscopic urological and bariatric surgery. Key region's of focus lie in minimally invasive laparoscopic devices which are cost effective, laparoscopic instruments which are in the mid range price bracket and also modular visualisation systems which can be used in tier two and three hospitals. In addition, there are training tools which help surgeons learn the techniques of minimally invasive surgery. The laparoscopic equipment market is highly fragmented, with local and regional suppliers competing on price in relation to standard instruments and trocars. Meanwhile, international companies maintain a competitive advantage in the field of energy equipment, high end visualisation systems and robotic laparoscopy. As a result the market divides into two distinct categories based on technology and price. Government backed capacity increases are one factor that is contributing to growth in a particular region. In addition there is a rise in private investment in hospitals, tourist visits for medical care in a number of region's, and a demand for less invasive surgery by a rising middle class. It is these factors that make investing in laparoscopic devices in this region a worthwhile option for the long term. The devices must be capable of being upgraded and varied in design to accommodate a range of different budgets and infrastructure.

Market Dynamics and Supply Chain

Driver: Growing Demand for Minimally Invasive Surgeries Combined with Aging Population and Rising Chronic Diseases

Increasing preference for minimally invasive surgical procedures and the global rise in chronic diseases are also key growth factors driving the laparoscopic devices market. Patients and healthcare providers favor laparoscopic surgery over open surgery due to benefits such as smaller incisions, less postoperative pain, faster recovery, and shorter hospital stays, leading to higher procedure volumes. Parallelly, the aging population is also more susceptible to conditions like gallbladder disease, hernias, gynecological disorders, and colorectal issues, which often require surgical intervention. This demographic shift, combined with a rise in lifestyle‑related chronic illnesses such as obesity and diabetes, fuels demand for laparoscopic interventions. As procedure counts grow, hospitals and surgical centers invest in advanced laparoscopic equipment including high‑definition imaging systems and energy‑based tools, reinforcing market expansion and technological adoption across regions.

Technological progress in 3D imaging systems and robotic assisted laparoscopic platforms significantly enhances surgeon capability and procedural outcomes. These innovations provide superior depth perception, precision instrument control, and ergonomics, enabling complex surgeries with improved safety and efficiency. As a result, adoption rates of advanced laparoscopic solutions in specialties such as gynecology, urology, and general surgery are also increasing, driving market growth and differentiation.

Restraint: High Initial Equipment Costs and Limited Reimbursement Curtail Adoption in Emerging Markets

The steep purchase price of advanced laparoscopic systems, including 3D imaging and robotic‑assisted platforms, limits adoption among small and mid‑sized hospitals, especially in developing regions. Budget constraints force facilities to delay upgrades or continue using conventional tools, reducing overall market revenue. Additionally, inconsistent reimbursement policies for minimally invasive procedures in certain countries discourage healthcare providers from investing in costly laparoscopic technologies, dampening demand and slowing regional market growth.

Opportunity: Upgrading laparoscopic energy systems and trocars for outpatient procedures in global ambulatory surgical centers and Rising bariatric surgery volumes using advanced Laparoscopic Devices among obese adults in the United States

As general surgery procedures are increasingly being relocated to day surgery centres around the world, laparoscopic equipment suited to ambulatory care is becoming the high end of the market. Existing endoscopic and laparoscopic facilities need more efficient systems to speed up the process of surgical procedures. These systems should include quick sterilizing devices, faster laparoscopic tools and instruments and quicker surgical closure systems. This would lead to patients being discharged on the same day and quicker hospital room turnovers. As yet, partnerships between central laboratories and clinical chains to standardise procedure packs and subscription based service models remain unexplored region's. Trocars are in a position to perform well, corresponding with global growth that is forecast to go from $4.28 billion in the year 2025 to $6.28 billion by 2030.

The increasing number of people suffering from obesity within the US and the insurance companies drive to reduce the time patients stay in the hospital for recovery has led to an increase in the number of bariatric surgeries carried out using laparoscopic techniques. Minimally invasive surgical procedures require ergonomic laparoscopic instruments featuring precise heat management and the appropriate laparoscope attachments. There is a considerable need for both replacement and initial installation of the equipment in mid size hospitals and the clinics which specialise in metabolic issues. The energy industry is forecasted to grow the fastest of all the sectors, with an estimated rise from $6.87 billion in 2025 to $10.71 billion by 2030 due to global expansion.

Challenge: Steep Learning Curve and Training Gaps Restrict Widespread Clinical Implementation

Laparoscopic surgery requires significant surgeon expertise and training to master hand‑eye coordination and use of complex instruments. Many facilities lack structured training programs, resulting in procedural inefficiencies, longer operating times, and higher risk of complications, which can deter adoption. This skills gap affects utilization rates and clinician preference for traditional open surgery in certain settings, influencing procedure volumes and reducing demand for advanced laparoscopic devices despite clinical benefits.

Supply Chain Landscape

Laparoscopic Devices Sourcing

Olympus CorporationB. Braun Melsungen AG

Component Manufacturing

Medtronic plcStryker Corporation

Surgical Instrument Distribution

Johnson & JohnsonOlympus Corporation

Minimally Invasive Surgery

HospitalsAmbulatory surgical centers

Laparoscopic Devices Sourcing

Olympus CorporationB. Braun Melsungen AG

Component Manufacturing

Medtronic plcStryker Corporation

Surgical Instrument Distribution

Johnson & JohnsonOlympus Corporation

Minimally Invasive Surgery

HospitalsAmbulatory surgical centers

Laparoscopic Devices - Supply Chain

Use Cases of Laparoscopic Devices in Bariatric & Urological

Bariatric : Bariatric procedures increasingly rely on laparoscopic devices such as laparoscopes, trocars, stapling systems, graspers, and energy based sealing instruments to perform minimally invasive weight loss surgeries including sleeve gastrectomy and gastric bypass. These devices are mainly used in hospitals and specialized surgical centers to enable precise tissue handling, secure vessel sealing, and controlled resection through small incisions. This approach reduces postoperative pain, shortens hospital stay, and improves recovery. Leading players such as Medtronic, Johnson and Johnson Ethicon, Olympus, and Intuitive Surgical hold strong positions due to comprehensive portfolios, advanced visualization, and reliable surgical performance.

Urological : Urological procedures widely use laparoscopic devices such as laparoscopes, trocars, and advanced energy based instruments in hospitals and ambulatory surgical centers to treat conditions involving the prostate, kidneys, and urinary tract. These devices enable minimally invasive surgeries like laparoscopic prostatectomy and nephrectomy with improved visualization, smaller incisions, and reduced blood loss. Faster recovery, lower complication rates, and shorter hospital stays drive adoption. Key players including Medtronic, Olympus, Johnson and Johnson, Karl Storz, and Intuitive Surgical maintain strong market positions through technologically advanced and reliable urological laparoscopic solutions.

Gynecological : In gynecological procedures, laparoscopic devices such as laparoscopes, trocars, graspers, energy based instruments, and suction irrigation systems are commonly used by hospitals and ambulatory surgical centers to perform minimally invasive surgeries including hysterectomy, myomectomy, ovarian cyst removal, and endometriosis treatment. These devices improve surgical precision, visualization, and procedural control while reducing blood loss, postoperative pain, and hospital stay. Leading companies such as Medtronic, Johnson and Johnson Ethicon, Stryker, Olympus, and Karl Storz dominate this application due to their advanced imaging technologies, reliable instrumentation, and strong clinical adoption worldwide.

Recent Developments

Recent developments in the laparoscopic devices market show accelerated adoption of advanced minimally invasive surgery tools, including robotic‑assisted platforms and high‑definition visualization systems, enhancing surgical precision and procedural outcomes. Integration of AI‑guided imaging, 3D and 4K optics, and tele‑surgery support is improving intraoperative decision‑making and expanding use in complex gynecological and bariatric procedures. Hospitals increasingly view these technologies as strategic investments in surgical efficiency and patient care, driving demand in ambulatory surgical centers and teaching institutions. A key trend remains the rise of robotic‑assisted laparoscopy, which is reshaping procedure volumes and competitive dynamics.

March 2024 : Johnson & Johnson MedTech secured an Investigational Device Exemption (IDE) from the FDA for its OTTAVA robotic surgical system, enabling U.S. clinical trials. The system is designed to support soft‑tissue, laparoscopic, hybrid, and open procedures, demonstrating J&J’s entry into advanced surgical robotics and strengthening its minimally invasive surgery portfolio.

October 2025 : Medtronic initiated an IDE clinical study for its Hugo robotic‑assisted system in gynecological procedures, completing initial total hysterectomy cases in October 2025, showing progress toward broader laparoscopic indications.

Impact of Industry Transitions on the Laparoscopic Devices Market

As a core segment of the Medical Device industry, the Laparoscopic Devices market develops in line with broader industry shifts. Over recent years, transitions such as Adoption of Robotic Assistance and Emergence of Single-Incision Laparoscopic Surgery have redefined priorities across the Medical Device sector, influencing how the Laparoscopic Devices market evolves in terms of demand, applications and competitive dynamics. These transitions highlight the structural changes shaping long-term growth opportunities.

Adoption of Robotic Assistance

The increasing demand for minimally invasive procedures has accelerated the growth of the Laparoscopic Devices industry. By 2030 the sector is expected to have grown by $2 billion due to robotic surgery. As the healthcare industry increasingly focuses on laparoscopic techniques and improved patient care, interest in comprehensive systems has grown. These systems integrate laparoscopic tools with surgical robotic systems, imaging capabilities, and OR operational efficiency. The acceleration of this process means that medical equipment replacement cycles are now occurring at a faster rate. This has led to increased sales of high tech medical systems and is causing a shift in the way that hospitals are spending money on capital projects. Hospitals are increasingly opting for the most modern, robot assisted laparoscopic technologies. Companies that are able to provide seamless integration of laparoscopic equipment with robotic systems as well as quicker patient recovery times will profit disproportionately and gain a significant market advantage over the forecast period.

Emergence of Single-Incision Laparoscopic Surgery

The laparoscopic devices industry is witnessing a significant shift toward Single-Incision Laparoscopic Surgery (SILS) technology, reflecting the broader trend of minimally invasive innovations. Unlike conventional laparoscopy that requires multiple incisions, SILS uses a single, strategically placed incision, typically at the navel, through which specialized instruments and high-definition cameras are inserted. This innovation not only reduces postoperative complications such as infections, bleeding, and scarring but also accelerates patient recovery and shortens hospital stays. Surgeons benefit from improved ergonomics and enhanced visualization, while patients experience better cosmetic outcomes and faster return to normal activities. Leading medical device manufacturers are investing in SILS-compatible instruments, advanced trocars, and multifunctional laparoscopic tools, driving adoption in gynecology, urology, and general surgery procedures worldwide, and reshaping the minimally invasive surgical landscape.